MEB-2300A NEUROPACK EVOKED POTENTIAL AND EMG MEASURING SYSTEM— 510(k) K120397

Name: FDA 510(k) clearance K120397
Creator: U.S. Food and Drug Administration
Published: 2012-09-19

Substantially Equivalent

Nihon Kohden Corp.

FDA 510(k) clearance K120397 for MEB-2300A NEUROPACK EVOKED POTENTIAL AND EMG MEASURING SYSTEM, Substantially Equivalent on 2012-09-19. Applicant: Nihon Kohden Corp.. Device class: 2.

Clearance details

Applicant: Nihon Kohden Corp.
Product code: Code GWF
Device class: Class 2
Regulation: 21 CFR 882.1870
Advisory panel: Neurology
Date received: 2012-02-08
Decision date: 2012-09-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Foothill, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GWF

view all

K253301 — BraiN20® (BraiN20)2026-06-27
K252842 — SafeOp 3: Neural Informatix System2026-01-11
K243982 — Nicolet EDX2025-01-22
K243495 — Natus Ultrapro S100 (982A0594)2024-12-12
K242345 — Delphi Stimulator2024-11-05

More clearances from Nihon Kohden Corp.

view all

K130238 — NIHON KOHDEN AE-918P NEURO UNIT2015-03-04
K122214 — TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTER (YG-213T)2013-05-21
K120888 — PSG-1100 SLEEP DIAGNOSTIC SYSTEM2012-11-09
K110594 — GF-210R MULTI-GAS MODULE FOR NOHON KOHDEN BEDSIDE MONITORS2011-10-28
K110410 — MS-120BK ELECTRIC STIMULATOR (EXTENSION UNIT)2011-08-04

Adverse events under product code GWF

product code GWF

Malfunction: 2,364
Other: 4
Total: 2,368

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.